Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-004607
Filing Date
2025-02-19
Accepted
2025-02-19 16:19:12
Documents
1
Period of Report
2025-02-17

Document Format Files

Seq Description Document Type Size
1 form4-02192025_090208.html 4  
1 form4-02192025_090208.xml 4 6596
  Complete submission text file 0001415889-25-004607.txt   8141
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Issuer) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 10 FINDERNE AVENUE BRIDGEWATER NJ 08807
Business Address
GOLL JOHN (Reporting) CIK: 0001779466 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39992 | Film No.: 25640316